These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm. Wu D; Ji S; Hu T Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485 [TBL] [Abstract][Full Text] [Related]
8. Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. Amir-Kroll H; Nussbaum G; Cohen IR J Immunol; 2003 Jun; 170(12):6165-71. PubMed ID: 12794147 [TBL] [Abstract][Full Text] [Related]
10. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Maitta RW; Datta K; Pirofski LA Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457 [TBL] [Abstract][Full Text] [Related]
12. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice. Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531 [TBL] [Abstract][Full Text] [Related]
13. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice. Tian H; Groner A; Boes M; Pirofski LA Infect Immun; 2007 Apr; 75(4):1643-50. PubMed ID: 17220309 [TBL] [Abstract][Full Text] [Related]
14. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate. Lu CH; Lee CJ; Kind P Infect Immun; 1994 Jul; 62(7):2754-60. PubMed ID: 8005665 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity in mice of pneumococcal glycoconjugate vaccines using pneumococcal protein carriers. Lee CJ; Wang TR; Frasch CE Vaccine; 2001 Apr; 19(23-24):3216-25. PubMed ID: 11312018 [TBL] [Abstract][Full Text] [Related]
16. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination. Rabquer B; Smithson SL; Shriner A; Julie Westerink MA Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780 [TBL] [Abstract][Full Text] [Related]
17. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae. Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973 [TBL] [Abstract][Full Text] [Related]
18. Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine. Zhang T; Yu W; Wang Y; Hu T Vaccine; 2015 Jun; 33(28):3208-14. PubMed ID: 25964170 [TBL] [Abstract][Full Text] [Related]
19. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae. Lin H; Peng Y; Lin Z; Zhang S; Guo Y Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527 [TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]